333 related articles for article (PubMed ID: 24949816)
1. Persistent organic pollutant levels in human visceral and subcutaneous adipose tissue in obese individuals--depot differences and dysmetabolism implications.
Pestana D; Faria G; Sá C; Fernandes VC; Teixeira D; Norberto S; Faria A; Meireles M; Marques C; Correia-Sá L; Cunha A; Guimarães JT; Taveira-Gomes A; Santos AC; Domingues VF; Delerue-Matos C; Monteiro R; Calhau C
Environ Res; 2014 Aug; 133():170-7. PubMed ID: 24949816
[TBL] [Abstract][Full Text] [Related]
2. Pivotal Role for the Visceral Fat Compartment in the Release of Persistent Organic Pollutants During Weight Loss.
Dirinck E; Dirtu AC; Jorens PG; Malarvannan G; Covaci A; Van Gaal LF
J Clin Endocrinol Metab; 2015 Dec; 100(12):4463-71. PubMed ID: 26469381
[TBL] [Abstract][Full Text] [Related]
3. Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors.
Sitticharoon C; Chatree S; Churintaraphan M
Regul Pept; 2013 Aug; 185():65-72. PubMed ID: 23838112
[TBL] [Abstract][Full Text] [Related]
4. Exposure to persistent organic pollutants: relationship with abnormal glucose metabolism and visceral adiposity.
Dirinck EL; Dirtu AC; Govindan M; Covaci A; Van Gaal LF; Jorens PG
Diabetes Care; 2014 Jul; 37(7):1951-8. PubMed ID: 24963112
[TBL] [Abstract][Full Text] [Related]
5. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
[TBL] [Abstract][Full Text] [Related]
6. Adipose Y5R mRNA is higher in obese than non-obese humans and is correlated with obesity parameters.
Chatree S; Sitticharoon C; Maikaew P; Uawithya P; Chearskul S
Exp Biol Med (Maywood); 2018 May; 243(9):786-795. PubMed ID: 29763369
[TBL] [Abstract][Full Text] [Related]
7. The metabolically healthy but obese phenotype is associated with lower plasma levels of persistent organic pollutants as compared to the metabolically abnormal obese phenotype.
Gauthier MS; Rabasa-Lhoret R; Prud'homme D; Karelis AD; Geng D; van Bavel B; Ruzzin J
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1061-6. PubMed ID: 24606089
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of persistent organic pollutants in relation to visceral and subcutaneous adipose tissue by abdominal MRI.
Roos V; Rönn M; Salihovic S; Lind L; van Bavel B; Kullberg J; Johansson L; Ahlström H; Lind PM
Obesity (Silver Spring); 2013 Feb; 21(2):413-8. PubMed ID: 23532994
[TBL] [Abstract][Full Text] [Related]
9. Interleukins 6 and 15 Levels Are Higher in Subcutaneous Adipose Tissue, but Obesity Is Associated with Their Increased Content in Visceral Fat Depots.
Jonas MI; Kurylowicz A; Bartoszewicz Z; Lisik W; Jonas M; Wierzbicki Z; Chmura A; Pruszczyk P; Puzianowska-Kuznicka M
Int J Mol Sci; 2015 Oct; 16(10):25817-30. PubMed ID: 26516848
[TBL] [Abstract][Full Text] [Related]
10. The association between obesity and mortality in the elderly differs by serum concentrations of persistent organic pollutants: a possible explanation for the obesity paradox.
Hong NS; Kim KS; Lee IK; Lind PM; Lind L; Jacobs DR; Lee DH
Int J Obes (Lond); 2012 Sep; 36(9):1170-5. PubMed ID: 21946706
[TBL] [Abstract][Full Text] [Related]
11. Relationship between fat cell size and number and fatty acid composition in adipose tissue from different fat depots in overweight/obese humans.
Garaulet M; Hernandez-Morante JJ; Lujan J; Tebar FJ; Zamora S
Int J Obes (Lond); 2006 Jun; 30(6):899-905. PubMed ID: 16446749
[TBL] [Abstract][Full Text] [Related]
12. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes.
Song YS; Lee SK; Jang YJ; Park HS; Kim JH; Lee YJ; Heo YS
Diabetes Res Clin Pract; 2013 Sep; 101(3):341-8. PubMed ID: 23876548
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study.
Lee J; Lee JY; Lee JH; Jung SM; Suh YS; Koh JH; Kwok SK; Ju JH; Park KS; Park SH
Arthritis Res Ther; 2015 Mar; 17(1):79. PubMed ID: 25889813
[TBL] [Abstract][Full Text] [Related]
14. The impact of obesity on secretion of adiponectin multimeric isoforms differs in visceral and subcutaneous adipose tissue.
Kovacova Z; Tencerova M; Roussel B; Wedellova Z; Rossmeislova L; Langin D; Polak J; Stich V
Int J Obes (Lond); 2012 Oct; 36(10):1360-5. PubMed ID: 22143618
[TBL] [Abstract][Full Text] [Related]
15. Amyloid precursor protein expression is upregulated in adipocytes in obesity.
Lee YH; Tharp WG; Maple RL; Nair S; Permana PA; Pratley RE
Obesity (Silver Spring); 2008 Jul; 16(7):1493-500. PubMed ID: 18483477
[TBL] [Abstract][Full Text] [Related]
16. Performance of abdominal bioelectrical impedance analysis and comparison with other known parameters in predicting the metabolic syndrome.
Mousa U; Kut A; Bozkus Y; Cicek Demir C; Anil C; Bascil Tutuncu N
Exp Clin Endocrinol Diabetes; 2013 Jul; 121(7):391-6. PubMed ID: 23696479
[TBL] [Abstract][Full Text] [Related]
17. Visceral fat cell lipolysis and cardiovascular risk factors in obesity.
Andersson DP; Löfgren P; Thorell A; Arner P; Hoffstedt J
Horm Metab Res; 2011 Oct; 43(11):809-15. PubMed ID: 22009377
[TBL] [Abstract][Full Text] [Related]
18. Differences in the redox status of human visceral and subcutaneous adipose tissues--relationships to obesity and metabolic risk.
Jankovic A; Korac A; Srdic-Galic B; Buzadzic B; Otasevic V; Stancic A; Vucetic M; Markelic M; Velickovic K; Golic I; Korac B
Metabolism; 2014 May; 63(5):661-71. PubMed ID: 24582138
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor and interferon-γ inducible protein-10 are related to visceral adiposity.
Faber DR; van der Graaf Y; Westerink J; Kanhai DA; Monajemi H; Visseren FL;
Eur J Clin Invest; 2013 Apr; 43(4):369-78. PubMed ID: 23398210
[TBL] [Abstract][Full Text] [Related]
20. Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women.
Liu A; McLaughlin T; Liu T; Sherman A; Yee G; Abbasi F; Lamendola C; Morton J; Cushman SW; Reaven GM; Tsao PS
Obes Surg; 2009 Nov; 19(11):1564-73. PubMed ID: 19711137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
